Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 100

    Sun Pharma files application for arthritis drug Tildrakizumab in Japan

    Sun Pharma files application for arthritis drug Tildrakizumab in Japan

    Farhat Nasim2 Aug 2019 10:00 AM IST
    Sun Pharma is committed to growing its global dermatology franchise, with Tildrakizumab as its lead product.New Delhi: Sun Pharmaceutical on Thursday...
    Biocon, Mylan launch biosimilar Ogivri for treatment of breast, stomach cancer in Australia

    Biocon, Mylan launch biosimilar Ogivri for treatment of breast, stomach cancer in Australia

    Medical Dialogues Bureau2 Aug 2019 9:45 AM IST
    Ogivri is the first trastuzumab biosimilar approved and launched in Australia and available on the Pharmaceutical Benefits Scheme (PBS), Biocon and...
    Strides Pharma independent director Sangita Reddy to step down

    Strides Pharma independent director Sangita Reddy to step down

    Medical Dialogues Bureau2 Aug 2019 9:30 AM IST
    In spite of Sangita Reddy's preoccupation as a successful entrepreneur, she contributed significantly to the company's growth particularly when it was...
    GSK Consumer Healthcare net profit rises by 24 percent to Rs 248 crore in Q1

    GSK Consumer Healthcare net profit rises by 24 percent to Rs 248 crore in Q1

    Farhat Nasim2 Aug 2019 9:15 AM IST
    The company had posted a net profit of Rs 200.44 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Consumer Healthcare said...
    Pharma companies resist Trump plan to import drugs

    Pharma companies resist Trump plan to import drugs

    Medical Dialogues Bureau2 Aug 2019 9:00 AM IST
    The U.S. Department of Health and Human Services (HHS) said it and the Food and Drug Administration will propose a rule that will allow it to...
    CDSCO mandates filing of online application for veterinary drugs on new SUGAM portal

    CDSCO mandates filing of online application for veterinary drugs on new SUGAM portal

    Farhat Nasim1 Aug 2019 10:57 AM IST
    New Delhi: Through a recent notification, the apex drug regulatory body Central Drugs Standard Control Organization (CDSCO) has informed to file...
    Sun Pharma to ramp up global speciality business; eyes "low-to-mid teens" growth in revenues for FY20

    Sun Pharma to ramp up global speciality business; eyes "low-to-mid teens" growth in revenues for FY20

    Medical Dialogues Bureau1 Aug 2019 10:00 AM IST
    The company is targeting key ailments like psoriasis to gradually ramp up its global speciality business, Dilip Shanghvi said adding that Sun Pharma...
    Biocon CSR arm unveils integrated program for Non-Communicable Diseases screening

    Biocon CSR arm unveils integrated program for Non-Communicable Diseases screening

    Medical Dialogues Bureau1 Aug 2019 9:30 AM IST
    In her communique, Dr Kiran Mazumdar Shaw, Managing Trustee, Biocon Foundation said, “We appreciate the sincere efforts of our Pourakarmikas to...
    Cadila Healthcare Ankleshwar facility successfully completes USFDA inspection

    Cadila Healthcare Ankleshwar facility successfully completes USFDA inspection

    Medical Dialogues Bureau1 Aug 2019 9:25 AM IST
    "The United States Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredient manufacturing facility located at...
    Dr Reddys net profit up by 45 percent to Rs 663 crore for June quarter

    Dr Reddys net profit up by 45 percent to Rs 663 crore for June quarter

    Medical Dialogues Bureau1 Aug 2019 9:15 AM IST
    "This quarter, we grew in most of our key markets and hope to continue this momentum with a sharper focus on performance," Dr Reddy's Laboratories...
    Bayer, Orion prostate cancer drug Daroluramide wins USFDA nod

    Bayer, Orion prostate cancer drug Daroluramide wins USFDA nod

    Medical Dialogues Bureau1 Aug 2019 9:00 AM IST
    According to the 2014 deal, Bayer has the right to commercialise daroluramide globally while Orion will manufacture the product and receive milestone...
    Dr Reddys anticipates USFDA inspection of Srikakulam plant by year-end

    Dr Reddy's anticipates USFDA inspection of Srikakulam plant by year-end

    Medical Dialogues Bureau31 July 2019 9:46 AM IST
    The USFDA had issued a warning letter in November 2015 relating to Current Good Manufacturing Practice (CGMP) deviations at Dr Reddy's API...
    PrevNext

    Popular Stories

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Edelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a day

    Edelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a day

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Top Pharmacy Courses That Rule the Industry

    Top Pharmacy Courses That Rule the Industry

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok